Nicholas Corcoran - 20 Feb 2023 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Role
SVP of Supply Chain and Operations
Signature
By: /s/ Stephen Gordon, Attorney-in-Fact
Issuer symbol
TMDX
Transactions as of
20 Feb 2023
Net transactions value
$0
Form type
4
Filing time
22 Feb 2023, 19:00:32 UTC
Previous filing
02 Feb 2023
Next filing
27 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMDX Common Stock Award $0 +12,886 $0.000000 12,886 20 Feb 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMDX Stock Option (Right to Buy) Award $0 +19,732 $0.000000 19,732 20 Feb 2023 Common Stock 19,732 $66.10 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 12,886 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F2 The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 20, 2023 until the option is fully vested on February 20, 2027, subject to continued service.

Remarks:

SVP of Supply Chain and Operations